| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.67 | 0.0005 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.55 | 0.008 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.49 | 0.01 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.48 | 0.01 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.47 | 0.005 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.43 | 0.04 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.4 | 0.04 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.38 | 0.06 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.36 | 0.07 |